- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01278420
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
June 13, 2012 updated by: Innovative Medical
The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Study Overview
Detailed Description
The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Barbara, California, United States, 93101
- Active, not recruiting
- Sansum- Santa Barbara medical foundation Clinic
-
-
Florida
-
Boynton Beach, Florida, United States, 33426
- Recruiting
- Katzen Eye Care & Laser Center
-
Principal Investigator:
- Larry Katzen, MD
-
Miami, Florida, United States, 33176
- Recruiting
- The Center for Excellence in Eye Care
-
Principal Investigator:
- William Trattler, MD
-
-
Illinois
-
Lake Villa,, Illinois, United States, 60046
- Recruiting
- Jackson Eye, SC
-
-
Indiana
-
Indianapolis, Indiana, United States, 46256
- Recruiting
- Eye Surgeons of Indiana
-
Principal Investigator:
- Kevin Waltz, MD
-
-
Ohio
-
Breckville, Ohio, United States, 44141
- Recruiting
- Cleveland Eye Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 or greater
- Bilateral condition (cataracts or Presbyopia) for which phacoemulsification and posterior IOL implantation has been planned for both eyes
- Visual potential of 20/25 or better in each eye after cataract removal and IOL implantation
- Clear intraocular media other than cataract
- Normal OCT of the macula
- No evidence of Keratoconus or significant irregular astigmatism on Preoperative topography
- No evidence of Epithelial Basement Membrane Dystrophy on Slit lamp Exam
- Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
Exclusion Criteria:
- Use of systemic or ocular medications that may affect vision
- Uncontrolled systemic or ocular disease
- History of ocular trauma
- History of intraocular, extraocular Muscle, or corneal surgery (including laser vision correction)
- Amblyopia or strabismus
- Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.)
- Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal disorders) that are predicted to cause future acuity losses to a level of 20/25 or worse
- Subjects who may be expected to require retinal laser treatment or other surgical intervention (i.e patients with diabetic retinopathy)
- Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome)
- Contact lens usage within 2 months for PMMA contacts lenses, 2 weeks for gas permeable lenses or 3 days for extended-wear and daily-wear soft contact lenses
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Tecnis MF
|
30 subjects will be implanted with the Tecnis MF
|
|
Other: ReSTOR
|
30 subjects will be implanted with ReSTOR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Refraction
Time Frame: 1 year
|
1 year
|
|
Distance Visual Acuities
Time Frame: 1 year
|
1 year
|
|
Near Visual Acuities
Time Frame: 1 year
|
1 year
|
|
Intermediate Acuities
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mitch Jackson, MD, Jackson Eye
- Principal Investigator: Larry Katzen, MD, Katzen Eye Care & Laser Center
- Principal Investigator: Kevin Waltz, MD, Eye Surgeons of Indiana
- Principal Investigator: Shamik Bafna, MD, Clevland Eye Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Anticipated)
December 1, 2012
Study Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
August 27, 2010
First Submitted That Met QC Criteria
January 14, 2011
First Posted (Estimate)
January 17, 2011
Study Record Updates
Last Update Posted (Estimate)
June 14, 2012
Last Update Submitted That Met QC Criteria
June 13, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TMF vs Restor MF 3D
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingCataract | Cataract Bilateral | Cataract Surgery
Clinical Trials on Tecnis MF
-
Alcon ResearchCompleted
-
Innovative MedicalCompletedCataractUnited States
-
Innovative MedicalCompletedTo Collect Information About Visual Outcomes and Participant SatisfactionUnited States
-
Innovative MedicalCompletedAphakiaUnited States
-
Tokat Gaziosmanpasa UniversityCompleted
-
Empire Eye and Laser CenterJohnson & Johnson Surgical Vision, Inc.CompletedCataract | PresbyopiaUnited States
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
Epirium Bio Inc.CompletedHealthy VolunteersUnited States
-
Bausch & Lomb IncorporatedCompleted
-
Coastal Eye Surgeons PLLCNot yet recruiting